Contenido principal del artículo

Teresa Cambil-Molina
Servicio de Medicina Nuclear y Servicio de Endocrinología y Nutrición. Hospital Universitario Virgen Macarena. Sevilla
España
Dr Tomas Martin
Servicio de Medicina Nuclear y Servicio de Endocrinología y Nutrición. Hospital Universitario Virgen Macarena. Sevilla
España
https://orcid.org/0000-0003-2834-4385
Vol. 13 Núm. 2 (2022), Artículo de revisión, Páginas e27456
DOI: https://doi.org/10.14201/orl.27456
Derechos de autor Cómo citar

Resumen

Introducción y objetivo: La cicatrización y los planos tisulares alterados se suman a la ya compleja anatomía del cuello y dificultan la localización de recidivas o metástasis no palpables en las reintervenciones cervicales del cáncer de tiroides. Síntesis: Describimos el uso de diversos técnicos de señalización empleadas para optimizar la cirugía y los resultados terapéuticos de pacientes con carcinoma papilar de tiroides con enfermedad cervical persistente o metastásica. Especialmente nos centramos en la técnica de localización utilizando semillas radiactivas (RSL) en la que se ha descrito, al igual que en la mama, excelentes resultados. Conclusiones: La RSL es una técnica segura, asociada a una mayor satisfacción del cirujano, con excelente tolerancia por el paciente, que, además, reduce el tiempo de la intervención quirúrgica proporciona mejores resultados cosméticos reduciendo el riesgo de morbilidad en comparación con el uso de colorantes, arpones y tatuajes. Además, permite el desacoplamiento completo de los programas de radiología y cirugía optimizando los tiempos y la programación de los quirófanos.
 

Descargas

La descarga de datos todavía no está disponible.

Detalles del artículo

Citas

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid [Internet]. 2016 [citado el 20/04/2019]; 26(1):1–133. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26462967

Frilling A, Görges R, Tecklenborg K, Gassmann P, Bockhorn M, Clausen M, et al. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery [Internet]. 2000 [citado el 20/04/2019]; 128(6):1067–1074. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0039606000662025

Ryu YJ, Cho JS, Yoon JH, Park MH. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection. World J Surg Oncol [Internet]. 2018 [citado el 20/04/2019]; 16(1):205. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30314503

Yang L, Shen W, Sakamoto N. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol [Internet]. 2013 [citado el 20/04/2019]; 31(4):468–474. Disponible en: https://ascopubs.org/doi/10.1200/JCO.2012.42.4457

Scheumann GFW, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg [Internet]. 1994 [citado el 20/04/2019]; 18(4):559–567. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/7725745

Wang TS, Evans DB, Fareau GG, Carroll T, Yen TW. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer [Internet]. Vol. 19, Annals of Surgical Oncology. 2012 [citado el 20/04/2019]. p. 4217–4222. Disponible en: https://www.springerlink.com/index/10.1245/s10434-012-2594-x

Adam MA, Thomas S, Hyslop T, Scheri RP, Roman SA, Sosa JA. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. J Clin Oncol [Internet]. 2016 [citado el 20/04/2019]; 34(36):4415–4420. Disponible en: https://ascopubs.org/doi/10.1200/JCO.2016.68.9372

Ferris RL, Baloch Z, Bernet V, Chen A, Fahey TJ, Ganly I, et al. American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. Thyroid. 2015; 25(7):760-768.

Tufano RP, Clayman G, Heller KS, Inabnet WB, Kebebew E, Shaha A, et al. Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: A critical review of the risks and benefits of surgical intervention versus active surveillance [Internet]. Vol. 25, Thyroid. Thyroid; 2015 [citado el 12/10/2021]. p. 15–27. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25246079/

Haser GC, Tuttle RM, Su HK, Alon EE, Bergman D, Bernet V, et al. Active Surveillance for Papillary Thyroid Microcarcinoma: New Challenges and Opportunities for the Health Care System. Endocr Pract [Internet]. 2016 [citado el 20/04/2019]; 22(5):602–611. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26799628

Lang BH-H, Lee GCC, Ng CPC, Wong KP, Wan KY, Lo C-Y. Evaluating the morbidity and efficacy of reoperative surgery in the central compartment for persistent/recurrent papillary thyroid carcinoma. World J Surg [Internet]. 2013 [citado el 20/04/2019]; 37(12):2853–2859. Disponible en: https://link.springer.com/10.1007/s00268-013-2202-7

Shaha A. Recurrent Differentiated Thyroid Cancer. Endocr Pract [Internet]. 2012 [citado el 20/04/2019]; 18(4):600–603. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22849875

Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L, et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg [Internet]. 2004 [citado el 20/04/2019]; 130(10):1214–1216. Disponible en: https://archotol.jamanetwork.com/article.aspx?doi=10.1001/archotol.130.10.1214

Roh JL, Park JY, Kim JM, Song CJ. Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Oncol [Internet]. 2009 [citado el 16/10/2021]; 99(1):28–31. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18942072/

Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer [Internet]. Vol. 19, Thyroid. Thyroid; 2009 [citado el 16/10/2021]. p. 1363–1372. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20001718/

Coquia SF, Chu LC, Hamper UM. The role of sonography in thyroid cancer. Radiol Clin North Am. 2014 Nov 1; 52(6):1283–1294.

Giles YS, Sarici IS, Tunca F, Sormaz IC, Salmaslio?lu A, Adalet I, et al. The rate of operative success achieved with radioguided occult lesion localization and intraoperative ultrasonography in patients with recurrent papillary thyroid cancer. Surg (United States) [Internet]. 2014 [citado el 20/04/2019]; 156(5):1116–1126. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0039606014001822

Di Meo G, Prete FP, De Luca GM, Pasculli A, Sgaramella LI, Minerva F, et al. The value of intraoperative ultrasound in selective lateral cervical neck lymphadenectomy for papillary thyroid cancer: A prospective pilot study. Cancers (Basel). 2021; 13(11):2737.

Ertas B, Kaya H, Kurtulmus N, Yakupoglu A, Giray S, Unal OF, et al. Intraoperative ultrasonography is useful in surgical management of neck metastases in differentiated thyroid cancers. Endocr 2014 481 [Internet]. 2014 [citado el 16/10/2021]; 48(1):248–253. Disponible en: https://link.springer.com/article/10.1007/s12020-014-0287-x

Karwowski JK, Jeffrey RB, McDougall IR, Weigel RJ, Monchik JM, McHenry CR, et al. Intraoperative ultrasonography improves identification of recurrent thyroid cancer. Surgery [Internet]. 2002 [citado el 12/10/2021]; 132(6):924–929. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12490837/

Sippel RS, Elaraj DM, Poder L, Duh Q-Y, Kebebew E, Clark OH. Localization of Recurrent Thyroid Cancer Using Intraoperative Ultrasound-Guided Dye Injection. World J Surg [Internet]. 2009 [citado el 08/06/2019]; 33(3):434–439. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/18958519

Soprani F, Vito A De, Bondi F, Magliulo G, Rene SS, Cappi C, et al. Preoperative charcoal suspension tattoo for the detection of differentiated thyroid cancer recurrence. Mol Clin Oncol [Internet]. 2019 [citado el 12/10/2021]; 10(5):524. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466997/

Hartl DM, Chami L, Ghuzlan A Al, Leboulleux S, Baudin E, Schlumberger M, et al. Charcoal suspension tattoo localization for differentiated thyroid cancer recurrence. Ann Surg Oncol [Internet]. 2009 [citado el 12/10/2021]; 16(9):2602–2608. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19551443/

Yeon Park J, Hyuck Park N, Yoon Yi S, Ko MS, Jin Park H. Preoperative US-guided hookwire localization for nonpalpable cervical masses. J Clin Ultrasound [Internet]. 2012 May [citado el 12/10/2021]; 40(4):195–199. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22030838/

Salvatori M, Rufini V, Reale F, Samanes Gajate AM, Maussier ML, Revelli L, et al. Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg [Internet]. 2003 [citado el 20/04/2019]; 27(7):770–775. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/14509503

Samara E, Williams M, Howlett DC. Current applications of ultrasound-guided wire localization in head and neck surgery. Int J Oral Maxillofac Surg [Internet]. 2019 [citado el 12/10/2021]; 48(4):443–446. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30316663/

Triponez F, Poder L, Zarnegar R, Goldstein R, Roayaie K, Feldstein V, et al. Hook needle-guided excision of recurrent differentiated thyroid cancer in previously operated neck compartments: a safe technique for small, nonpalpable recurrent disease. J Clin Endocrinol Metab [Internet]. 2006 [citado el 20/04/2019]; 91(12):4943–7. Disponible en: https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2006-0386

Baena Fustegueras, JA, Herrerías González, F, Gatius Calderá, S, Fuente Juárez, MC, Ros Lápez, S, Rius Riu, F, Mestres Petit, N, et al. Magnetic detection of sentinel lymph node in papillary thyroid carcinoma: The MAGIC-PAT study results. Eur J Surg Oncol [Internet]. 2019 [citado el 17/10/2021]; Disponible en: https://doi.org/10.1016/j.ejso.2019.03.017

Travagli JP, Cailleux AF, Ricard M, Baudin E, Caillou B, Parmentier C, et al. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab [Internet]. 1998 [citado el 12/10/2021]; 83(8):2675–2680. Disponible en: https://pubmed.ncbi.nlm.nih.gov/9709930/

Rubello D, Salvatori M, Ardito G, Mariani G, Al-Nahhas A, Gross MD, et al. Iodine-131 radio-guided surgery in differentiated thyroid cancer: Outcome on 31 patients and review of the literature. Biomed Pharmacother [Internet]. 2007 [citado el 12/10/2021]; 61(8):477–481. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17761397/

Rubello D, Salvatori M, Casara D, Piotto A, Toniato A, Gross MD, et al. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer. Eur J Surg Oncol. 2007 Sep; 33(7):902–6.

Negele T, Meisetschläger G, Brückner T, Scheidhauer K, Schwaiger M, Vogelsang H. Radio-guided surgery for persistent differentiated papillary thyroid cancer: Case presentations and review of the literature. Langenbeck’s Arch Surg. 2006 Jun;391(3):178–186.

Mansberg R, Crawford B, Uren RF, Thompson JF. Minimally invasive radio-guided surgery for recurrent thyroid cancer using iodine-123. Clin Nucl Med [Internet]. 2005 Jan [citado el 12/10/2021]; 30(1):43–44. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15604973/

Carcoforo P, Portinari M, Feggi L, Panareo S, De Troia A, Zatelli MC, et al. Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. Surgery [Internet]. 2014 [citado el 20/04/2019]; 156(1):147–517. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0039606014001391

Terzio?lu T, Senyurek YG, Tunca F, Türkmen C, Mudun A, Salmasl?oglu A, et al. Excision efficiency of radioguided occult lesion localization in reoperative thyroid and parathyroid surgery. Thyroid [Internet]. 2010 [citado el 20/04/2019]; 20(11):1271–1278. Disponible en: https://www.liebertpub.com/doi/10.1089/thy.2009.0441

Tuncel M, Süslü N. Radioguided occult lesion localization in patients with recurrent thyroid cancer. Eur Arch Oto-Rhino-Laryngology. 2019.

Tükenmez M, Erbil Y, Barbaros U, Dural C, Salmaslioglu A, Aksoy D, et al. Radio-guided nonpalpable metastatic lymph node localization in patients with recurrent thyroid cancer. J Surg Oncol [Internet]. 2007 [citado el 12/10/2021]; 96(6):534–538. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17680637/

Gulcelik MA, Karaman N, Dogan L, Sahiner I, Akgul GG, Kahraman YS, et al. Radioguided occult lesion localization for locally recurrent thyroid carcinoma. Eur Arch Otorhinolaryngol [Internet]. 2017 Jul 13 [citado el 08/06/2019]; 274(7):2915–2919. Disponible en: http://link.springer.com/10.1007/s00405-017-4563-2

Ilgan S, Öztürk E, Yildiz R, Emer Ö, Ayan A, Görgülü S, et al. Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: A practical method for central compartment reoperations. Clin Nucl Med [Internet]. 2010 [citado el 12/10/2021]; 35(11):847–352. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20940540/

Van der Noordaa MEM, Pengel KE, Groen E, Van Werkhoven E, Rutgers EJT, Loo CE, et al. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium. Eur J Surg Oncol [Internet]. 2015 Apr [citado el 20/04/2019]; 41(4):553–558. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0748798315000554

Van Nijnatten TJA, Simons JM, Smidt ML, Van der Pol CC, Van Diest PJ, Jager A, et al. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Pros. Clin Breast Cancer [Internet]. 2017 Aug 1 [citado el 12/10/2021]; 17(5):399–402. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28487053/

Simons JM, Van Nijnatten TJA, Van Der Pol CC, Luiten EJT, Koppert LB, Smidt ML. Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging after Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis. Ann Surg. 2019 Mar 1; 269(3):432–442.

Donker M, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients the mari procedure. Ann Surg [Internet]. 2015 [citado el 12/10/2021]; 261(2):378–382. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24743607/

Straver ME, Loo CE, Alderliesten T, Rutgers EJT, Vrancken Peeters MTFD. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg [Internet]. 2010 Aug [citado el 12/10/2021]; 97(8):1226–1231. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20602508/

Garner HW, Bestic JM, Peterson JJ, Attia S, Wessell DE. Preoperative radioactive seed localization of nonpalpable soft tissue masses: an established localization technique with a new application. Skeletal Radiol [Internet]. 2017 Feb 24 [citado el 20/04/2019]; 46(2):209–216. Disponible en: http://link.springer.com/10.1007/s00256-016-2529-x

De Danschutter SJR, Schreinemakers JMJ, Kint PAM, Gobardhan PD, Adriaensen T, van der Laan L, et al. Iodine 125 Seed for Localization in Primary Hyperparathyroidism. Surg Innov [Internet]. 2016 Dec 20 [citado el 20/04/2019]; 23(6):593–597. Disponible en: http://journals.sagepub.com/doi/10.1177/1553350616663323

Gobardhan PD, Djamin RS, Romme PJHJ, De Wit PEJ, De Groot HGW, Adriaensen T, et al. The use of iodine seed (I-125) as a marker for the localisation of lung nodules in minimal invasive pulmonary surgery. Eur J Surg Oncol [Internet]. 2013 Sep [citado el 20/04/2019]; 39(9):945–950. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0748798313004496

Pérez Reyes M, Jiménez Mazure C, Pulido Roa I, Rodríguez Silva C. Image-guided excision with I125 seed in lymph node metastasis of medullary thyroid carcinoma. Cir Esp. 2020 Jun; 98(6):357.

Beniey M, Gauthier V, Coulombe G, El Khoury M, Nassif E. Radioactive seed localization in recurrent thyroid carcinoma: A case report. Otolaryngol Case Reports. 2020 Jun 1; 15.

Garner HW, Paz-Fumagalli R, Young GD. Preoperative Localization of Recurrence in the Thyroidectomy Bed Using a Radioactive Iodine 125 Seed. Otolaryngol Neck Surg [Internet]. 2018 Aug 24 [citado el 20/04/2019]; 159(2):394–397. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/29685086

Cambil T, Terrón JA, Marín C, Martín T. 125I radioactive seed localization (RSL) in surgery of cervical metastasis of thyroid cancer. Rev Esp Med Nucl Imagen Mol [Internet]. 2020 May 1 [citado el 12/10/2021]; 39(3):140–145. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32402777/

Bortz MD, Khokar A, Winchester DJ, Moo-Young TA, Ecanow DB, Ecanow JS, et al. Radioactive iodine-125 seed localization as an aid in reoperative neck surgery. Am J Surg. 2021 Mar 1;221(3):534–537.

Vilar Tabanera A, Ajuria O, Rioja ME, Cabañas Montero J. Selective Neck Dissection Guided by a Radioactive I125 Seed for Papillary Thyroid Carcinoma Recurrence. Cir Esp. 2020 Oct 1; 98(8):478–481.

Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non palpable breast lesions. Am J Surg [Internet]. 2010 Apr [citado el 20/04/2019]; 199(4):522–528. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0002961009005212

Eckerman K, Endo A. ICRP Publication 107. Nuclear decay data for dosimetric calculations. Ann ICRP [Internet]. 2008 Jun [citado el 20/04/2019]; 38(3):9–10. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19285593

Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Huq MS, Ibbott GS, et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys [Internet]. 2004 Mar 27 [citado el 20/04/2019]; 31(3):633–674. Disponible en: http://doi.wiley.com/10.1118/1.1646040

Goudreau SH, Joseph JP, Seiler SJ. Preoperative radioactive seed localization for nonpalpable breast lesions: Technique, pitfalls, and solutions. Radiographics [Internet]. 2015 Sep 1 [citado el 12/10/2021]; 35(5):1319–1334. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26274097/

Jakub J, Gray R. Starting a Radioactive Seed Localization Program. Ann Surg Oncol [Internet]. 2015 Oct 8 [citado el 20/04/2019]; 22(10):3197–3202. Disponible en: https://link.springer.com/10.1245/s10434-015-4719-5